Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-075687

Options or other derivatives

  • Chief Financial Officer acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Roche Corleen M. Chief Financial Officer 2025-08-06 Grant or award · Stock Option (right to buy) +300,000 300,000 D: show line 1 in the form
Roche Corleen M. Chief Financial Officer 2025-08-06 Grant or award · Restricted Stock Units +150,000 150,000 D: show line 2 in the form
Loading xslF345X05/tm2522878-2_4seq1.xml…